Atossa Genetics Inc. (NASDAQ: ATOS) is focused on improving breast health through the development of innovative laboratory services, medical devices and therapeutics. The company’s laboratory services are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. These services, as well as Atossa’s medical devices, are being developed so they can be used as companions to therapeutics aimed at the treatment of various breast health conditions. For more information, visit the company’s website at www.atossagenetics.com.